ストックスクリーナーアプリを入手
34.99
6.55%
2.15
プレマーケット:
34.99
前日終値:
$32.84
開ける：
$33.34
24時間の取引高:
500.05K
Relative Volume:
1.01
時価総額：
$1.69B
収益：
-
当期純損益:
-
株価収益率:
-
EPS:
-
ネットキャッシュフロー:
-
1週間 パフォーマンス:
-0.82%
1か月 パフォーマンス:
+6.03%
6か月 パフォーマンス:
+133.73%
1年 パフォーマンス:
+245.07%
1日の値動き範囲:
$32.24
$35.66
1週間の範囲:
$31.86
$35.66
52週間の値動き範囲:
$5.485
$36.53
Oruka Therapeutics Inc Stock (ORKA) Company Profile
Compare ORKA vs VRTX, REGN, ARGX, ALNY, ONC
| 株式 | 価格 | 時価総額 | 収益 | 当期純利益 | 現金流量 | EPS |
|---|---|---|---|---|---|---|
ORKA
Oruka Therapeutics Inc
|
34.99 | 1.59B | 0 | 0 | 0 | 0.00 |
|
VRTX
Vertex Pharmaceuticals Inc
|
477.89 | 120.48B | 12.07B | 3.95B | 3.19B | 15.33 |
|
REGN
Regeneron Pharmaceuticals Inc
|
787.50 | 81.05B | 14.34B | 4.50B | 3.77B | 41.56 |
|
ARGX
Argen X Se Adr
|
749.56 | 46.33B | 4.16B | 1.29B | 734.26M | 19.59 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
327.30 | 42.26B | 3.71B | 313.75M | 465.38M | 2.2571 |
|
ONC
Beone Medicines Ltd Adr
|
299.02 | 32.87B | 5.36B | 287.73M | 924.18M | 2.5229 |
Oruka Therapeutics Inc Stock (ORKA) Upgrades & Downgrades
| 日付 | アクション | アナリスト | 評価の変更 |
|---|---|---|---|
| 2025-12-18 | 開始されました | Piper Sandler | Overweight |
| 2025-11-13 | 開始されました | Jefferies | Buy |
| 2025-10-27 | 開始されました | Guggenheim | Buy |
| 2025-10-13 | 開始されました | Barclays | Overweight |
| 2025-05-22 | 開始されました | BTIG Research | Buy |
| 2025-02-04 | 開始されました | Wolfe Research | Outperform |
| 2024-10-11 | 開始されました | Stifel | Buy |
| 2024-10-07 | 開始されました | H.C. Wainwright | Buy |
| 2024-09-17 | 開始されました | Leerink Partners | Outperform |
| 2024-09-16 | 開始されました | TD Cowen | Buy |
| 2024-09-13 | 開始されました | Jefferies | Buy |
| 2018-02-27 | 開始されました | Ascendiant Capital Markets | Buy |
| 2013-10-09 | 開始されました | Dawson James | Buy |
すべてを表示
Oruka Therapeutics Inc (ORKA) 最新ニュース
Oruka Therapeutics, Inc. (NASDAQ:ORKA) Short Interest Down 17.2% in February - MarketBeat
Is Oruka Therapeutics Inc. forming bullish engulfing patternsJuly 2025 Rallies & Smart Allocation Stock Reports - mfd.ru
Oruka Therapeutics Inc expected to post a loss of 63 cents a shareEarnings Preview - TradingView
Oruka Therapeutics (NASDAQ:ORKA) Upgraded at Wall Street Zen - Defense World
Oruka Therapeutics, Inc. (ORKA) Stock Analysis: A 62% Upside Potential in the Biotech Arena - DirectorsTalk Interviews
Oruka Therapeutics (ORKA) Expected to Announce Earnings on Thursday - Defense World
Oruka Therapeutics stock hits 52-week high at 36.53 USD By Investing.com - Investing.com Australia
Oruka Therapeutics (NASDAQ:ORKA) Reaches New 52-Week HighWhat's Next? - MarketBeat
Oruka Therapeutics stock hits 52-week high at 36.53 USD - Investing.com
Oruka Therapeutics: A Potential Future Psoriasis Play (NASDAQ:ORKA) - Seeking Alpha
Empirical Financial Services LLC d.b.a. Empirical Wealth Management Acquires New Holdings in Oruka Therapeutics, Inc. $ORKA - Defense World
Oruka Therapeutics, Inc. (NASDAQ:ORKA) Receives Consensus Rating of “Moderate Buy” from Brokerages - Defense World
RTW INVESTMENTS, LP Expands Stake in Oruka Therapeutics Inc - GuruFocus
How Oruka Therapeutics Inc. stock performs in high volatility marketsJuly 2025 Summary & Stepwise Trade Signal Guides - mfd.ru
Oruka Therapeutics, Inc. (ORKA) Stock Analysis: A Promising 71.70% Potential Upside In Biotech Innovation - DirectorsTalk Interviews
Will Oruka Therapeutics Inc outperform tech stocksJuly 2025 Chart Watch & Low Risk Entry Point Guides - baoquankhu1.vn
Evaluating Oruka Therapeutics (ORKA) Valuation After Strong Recent Share Price Momentum - Yahoo Finance
Big Money Moves: Whats the beta of Uniti Group Inc stockGap Up & Risk Managed Investment Signals - baoquankhu1.vn
Aug Summary: Is Oruka Therapeutics Incs ROE strong enoughJuly 2025 Retail & Expert Approved Momentum Ideas - baoquankhu1.vn
Published on: 2026-02-15 16:13:39 - mfd.ru
Oruka Therapeutics, Inc. (ORKA) Stock Analysis: Promising 70% Upside Potential In Biotech - DirectorsTalk Interviews
How cyclical is Oruka Therapeutics Inc.’s revenue streamJuly 2025 Sector Moves & Verified Chart Pattern Trade Signals - mfd.ru
Candriam S.C.A. Buys 250,296 Shares of Oruka Therapeutics, Inc. $ORKA - MarketBeat
Is Oruka Therapeutics Inc. stock a contrarian buyWeekly Earnings Recap & Weekly Market Pulse Updates - mfd.ru
Will Oruka Therapeutics Inc. stock remain a Wall Street favoriteJuly 2025 Action & Accurate Buy Signal Alerts - mfd.ru
Oruka Therapeutics to Participate in Multiple Upcoming Conferences - The Manila Times
Oruka Therapeutics, Inc. (ORKA) Stock Analysis: A Promising 77% Upside Potential in the Biotech Sector - DirectorsTalk Interviews
Dow Update: What is Oruka Therapeutics Incs book value per share2025 Retail Activity & Verified Swing Trading Watchlists - baoquankhu1.vn
Clear Street says AbbVie move further validates Oruka Therapeutics’ strategy - TipRanks
Oruka Therapeutics, Inc. (NASDAQ:ORKA) Short Interest Down 31.3% in January - MarketBeat
Oruka Therapeutics, Inc. (NASDAQ:ORKA) Given Average Rating of "Moderate Buy" by Analysts - MarketBeat
Oruka Therapeutics, Inc. (NASDAQ:ORKA) Given Average Rating of “Moderate Buy” by Analysts - Defense World
Oruka Therapeutics, Inc. (ORKA) Stock Report: Biotechnology Pioneer Poised for 57.87% Upside - DirectorsTalk Interviews
Portfolio Update: Is Global Blue Group Holding AG Equity Warrant stock a top performer YTDQuarterly Growth Report & Long Hold Capital Preservation Plans - baoquankhu1.vn
How cyclical is Oruka Therapeutics Incs revenue streamWeekly Investment Recap & Safe Capital Growth Stock Tips - baoquankhu1.vn
How Early ORKA-002 Dosing Data At Oruka Therapeutics (ORKA) Has Changed Its Investment Story - simplywall.st
H.C. Wainwright Maintains Oruka Therapeutics(ORKA.US) With Buy Rating, Maintains Target Price $40 - 富途牛牛
Oruka Therapeutics (NASDAQ:ORKA) Shares Gap DownHere's What Happened - MarketBeat
Market Outlook: Does Oruka Therapeutics Inc stock have upside surprise potential2025 Market Overview & Stock Portfolio Risk Management - baoquankhu1.vn
Fed Meeting: Will Oruka Therapeutics Inc outperform tech stocksJuly 2025 Reactions & Entry Point Confirmation Signals - baoquankhu1.vn
RSI Check: Can GLPG outperform under higher oil pricesJuly 2025 Highlights & Daily Market Momentum Tracking - baoquankhu1.vn
Oruka Therapeutics (NASDAQ:ORKA) Sets New 52-Week HighWhat's Next? - MarketBeat
Oruka Therapeutics, Inc. (ORKA) Stock Price History & Data - Traders Union
Gains Report: Will Oruka Therapeutics Inc benefit from AI trendsGold Moves & Reliable Momentum Entry Alerts - baoquankhu1.vn
Aug Opening: Will ARTV outperform the market in YEAR2025 Major Catalysts & Low Drawdown Trading Techniques - baoquankhu1.vn
Assessing Oruka Therapeutics (ORKA) Valuation After Encouraging ORKA 002 Phase 1 Trial Results - Sahm
Oruka Therapeutics, Inc. (NASDAQ:ORKA) Short Interest Update - MarketBeat
Joana Goncalves Sells 7,000 Shares of Oruka Therapeutics (NASDAQ:ORKA) Stock - MarketBeat
Oruka Therapeutics stock hits 52-week high at 32.65 USD By Investing.com - Investing.com Nigeria
Oruka Therapeutics (ORKA) Is Up 23.1% After Extended-Dosing IL-17 Data for ORKA-002What's Changed - Sahm
Oruka Therapeutics (NASDAQ:ORKA) Sets New 12-Month HighHere's Why - MarketBeat
Oruka Therapeutics Inc (ORKA) 財務データ
Oruka Therapeutics Inc (ORKA) の財務データはありません。詳細については、他の銘柄を確認してください。
収益
当期純利益
現金流量
EPS
Oruka Therapeutics Inc (ORKA) インサイダートレーディング
| インサイダートレーディング | 関係 | 日付 | 取引 | コスト | #株式 | 値 ($) | #株式総数 |
|---|---|---|---|---|---|---|---|
| Sandler Laura Lee | Chief Operating Officer |
Mar 02 '26 |
Sale |
33.56 |
5,000 |
167,822 |
237,584 |
| Goncalves Joana | Chief Medical Officer |
Feb 17 '26 |
Option Exercise |
7.32 |
7,000 |
51,240 |
41,018 |
| Goncalves Joana | Chief Medical Officer |
Feb 17 '26 |
Sale |
32.37 |
7,000 |
226,559 |
34,018 |
| Goncalves Joana | Chief Medical Officer |
Jan 15 '26 |
Option Exercise |
7.32 |
7,000 |
51,240 |
8,518 |
| Goncalves Joana | Chief Medical Officer |
Jan 15 '26 |
Sale |
31.81 |
7,000 |
222,704 |
1,518 |
| Sandler Laura Lee | Chief Operating Officer |
Jan 02 '26 |
Option Exercise |
7.80 |
5,000 |
39,000 |
218,084 |
| Sandler Laura Lee | Chief Operating Officer |
Jan 02 '26 |
Sale |
28.52 |
13,000 |
370,795 |
205,084 |
0.11%
6.00%
大文字化:
|
ボリューム (24 時間):